Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Liu, Ya Fen ^a   Gao, Yan ^a   Chen, Mei Fang ^a   Cao, Bin ^b   Yang, Xiao Hua ^a   Wei, Lai ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Community acquired pneumonia; Diagnosis; Epidemiology; Etiology; Pneumonia; Polymerase chain reaction; ROC curve; Virus

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; VIRUS DNA; VIRUS RNA;

ADENOVIRUS; ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BOCAVIRUS; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DYSPNEA; ENTEROVIRUS; FEMALE; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN TISSUE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MIXED INFECTION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYCOPLASMA PNEUMONIAE; OUTPATIENT; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS 4; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; RHINOVIRUS; RISK FACTOR; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; THORAX PAIN; THROAT CULTURE; UNIVARIATE ANALYSIS; VIRUS DETECTION; VIRUS INFECTION;

EID: 84880024189     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-309     Document Type: Article

References (45)

1. Mandell LA. Epidemiology and etiology of community-acquired pneumonia. Infect Dis Clin North Am 2004, 18:761-776. 10.1016/j.idc.2004.08.003, 15555823.
2. National Center for Health Statistics Health, United States, 2006, with chartbook on trends in the health of Americans http://www.cdc.gov/nchs/data/hus/hus06.pdf, National Center for Health Statistics.
3. File TM, Marrie TJ. Burden of community acquired pneumonia in North American adults. Postgrad Med 2010, 122:130-141. 10.3810/pgm.2010.03.2130, 20203464.
4. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995, 333:1618-1624. 10.1056/NEJM199512143332408, 7477199.
5. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996, 275:134-141. 10.1001/jama.1996.03530260048030, 8531309.
6. Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, Mandaliya K, Getambu E, Gleeson F, Drobniewski F, Marsh K. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 2000, 355:1225-1230. 10.1016/S0140-6736(00)02089-4, 10770305.
7. Guthrie R. Community-acquired lower respiratory tract infections: etiology and treatment. Chest 2001, 120:2021-2034. 10.1378/chest.120.6.2021, 11742937.
8. Shin GY. What about viral community acquired pneumonias?. BMJ 2008, 337:a598. 10.1136/bmj.a598, 2443564, 18595907.
9. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011, 377:1264-1275. 10.1016/S0140-6736(10)61459-6, 21435708.
10. Sun HL, Wang H, Chen MJ, Sun ZY, Yu YS, Hu BJ, Chu YZ, Liao K, Lei JE, Zhang B, Cao B, He QY, Zhang Z, Hu ZD. Antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2008. Chinese J Lab Med 2010, 33:224-229.
11. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010, 51:189-194. 10.1086/653535, 20540621.
12. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious diseases society of America; American thoracic society: infectious diseases society of America/American thoracic society consensus guidelines on the management of community- acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):27-72.
13. Halm EA, Teirstein AS. Clinical practice Management of community-acquired pneumonia. N Engl J Med 2002, 347:2039-2045. 10.1056/NEJMcp020499, 12490686, Clinical practice.
14. Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RT, Werno AM, Young SA, Chambers ST, Murdoch DR. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008, 63:42-48. 10.1136/thx.2006.075077, 17573440.
15. Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A, Shtainberg R, Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010, 138:811-816. 10.1378/chest.09-2717, 20363845.
16. Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, Grayson ML. Australian CAP Study Collaboration The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008, 46:1513-1521. 10.1086/586749, 18419484, Australian CAP Study Collaboration.
17. Cao B, Ren LL, Zhao F, Gonzalez R, Song SF, Bai L, Yin YD, Zhang YY, Liu YM, Guo P, Zhang JZ, Wang JW, Wang C. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur J Clin Microbiol Infect Dis 2010, 29:1443-1448. 10.1007/s10096-010-1003-2, 20623362.
18. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators: a worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007, 175:1086-1093. 10.1164/rccm.200603-350OC, 17332485.
19. Liu YN, Chen MJ, Zhao TM, Wang H, Wang R, Liu QF, Cai BQ, Cao B, Sun TY, Hu YJ, Xiu QY, Zhou X, Ding X, Yang L, Zhuo JS, Tang YC, Zhang KX, Liang DR, Lü XJ, Li SQ, Liu Y, Yu YS, Wei ZQ, Ying KJ, Zhao F, Chen P, Hou XN. A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China. Zhonghua Jie He He Hu Xi Za Zhi 2006, 29:3-8.
20. Bao Z, Yuan X, Wang L, Sun Y, Dong X. The incidence and etiology of community-acquired pneumonia in fever outpatients. Exp Biol Med 2012, 237:1256-1261.
21. Wulff-Burchfield E, Schell WA, Eckhardt AE, Pollack MG, Hua Z, Rouse JL, Pamula VK, Srinivasan V, Benton JL, Alexander BD, Wilfret DA, Kraft M, Cairns CB, Perfect JR, Mitchell TG. Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens. Diagn Microbiol Infect Dis 2010, 67:22-29. 10.1016/j.diagmicrobio.2009.12.020, 2854258, 20227222.
22. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 2011, 52(Suppl 4):296-304.
23. Osiowy C. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay. J Clin Microbiol 1998, 36:3149-3154. 105291, 9774555.
24. van Elden LJ, van Kraaij MG, Nijhuis M, Hendriksen KA, Dekker AW, Rozenberg-Arska M, van Loon AM. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis 2002, 34:177-183. 10.1086/338238, 11740705.
25. Nolte FS. Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia. Clin Infect Dis 2008, 47(Suppl 3):123-126.
26. Resti M, Micheli A, Moriondo M, Becciolini L, Cortimiglia M, Canessa C, Indolfi G, Bartolini E, de Martino M, Azzari C. Comparison of the effect of antibiotic treatment on the possibility to diagnose invasive pneumococcal disease by cultural or molecular methods: a prospective observational study of children with proven pneumococcal infection. Clin Ther 2009, 31:1266-1273. 10.1016/j.clinthera.2009.06.010, 19695393.
27. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000, 31:347-382. 10.1086/313954, 10987697.
28. de Roux A, Ewig S, García E, Marcos MA, Mensa J, Lode H, Torres A. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006, 27:795-800. 10.1183/09031936.06.00058605, 16585087.
29. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010, 50:202-209. 10.1086/648678, 20014950.
30. Gencay M, Roth M, Christ-Crain M, Mueller B, Tamm M, Stolz D. Single and multiple viral infections in lower respiratory tract infection. Respiration 2010, 80:560-567. 10.1159/000321355, 20861611.
31. Virus and bacteria in influenza. Br Med J 1972, 4:745-746. 1787053, 4646499.
32. Bakaletz LO. Developing animal models for polymicrobial diseases. Nat Rev Microbiol 2004, 2:552-568. 10.1038/nrmicro928, 15197391.
33. Small CL, Shaler CR, McCormick S, Jeyanathan M, Damjanovic D, Brown EG, Arck P, Jordana M, Kaushic C, Ashkar AA, Xing Z. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 2010, 184:2048-2056. 10.4049/jimmunol.0902772, 20083661.
34. Imakita M, Shiraki K, Yutani C, Ishibashi-Ueda H. Pneumonia caused byrhinovirus. Clin Infect Dis 2000, 30:611-612. 10.1086/313723, 10722460.
35. Monto AS. Epidemiology of viral respiratory infections. Am J Med 2002, 112(Suppl 6):4-12.
36. Falsey AR, Walsh EE. Viral pneumonia in older adults. Clin Infect Dis 2006, 42:518-524. 10.1086/499955, 16421796.
37. Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis 2006, 43:1016-1022. 10.1086/507638, 16983614.
38. Nair GB, Niederman MS. Community-acquired pneumonia: an unfinished battle. Med Clin North Am 2011, 95:1143-1161. 10.1016/j.mcna.2011.08.007, 22032432.
39. Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007, 7:10. 10.1186/1471-2334-7-10, 1821031, 17335562.
40. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008, 134:1141-1148. 10.1378/chest.08-0888, 18689592.
41. Ruiz-González A, Falguera M, Vives M, Nogués A, Porcel JM, Rubio-Caballero M. Community-acquired pneumonia: development of a bedside predictive model and scoring system to identify the aetiology. Respir Med 2000, 94:505-510. 10.1053/rmed.1999.0774, 10868716.
42. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004, 169:342-347. 10.1164/rccm.200309-1248OC, 14630621.
43. Falguera M, Trujillano J, Caro S, Menéndez R, Carratalà J, Ruiz-González A, Vilà M, García M, Porcel JM, Torres A. NAC-CALIDAD Study Group A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009, 49:409-416. 10.1086/600291, 19555286, NAC-CALIDAD Study Group.
44. Yang X, Yao Y, Chen M, Yang X, Xie Y, Liu Y, Zhao X, Gao Y, Wei L. Etiology and clinical characteristics of influenza-like illness (I004CI) in outpatients in Beijing, June 2010 to May 2011. PLoS One 2012, 7:e28786. 10.1371/journal.pone.0028786, 3251557, 22238581.
45. Ma HM, Lee KP, Woo J. Predictors of viral pneumonia: The need for viral testing in all patients hospitalized for nursing home-acquired pneumonia. Geriatr Gerontol Int 2013,